Cytomegalovirus ventriculoencephalitis in a bone marrow transplant recipient receiving antiviral maintenance: clinical and molecular evidence of drug resistance.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 11577375.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We describe a case of CMV ventriculoencephalitis in a severely immunocompromised bone marrow transplant recipient who was receiving combination therapy with ganciclovir and foscarnet for treatment of viremia and retinitis. Analysis of sequential viral isolates recovered from the patient's cerebrospinal fluid suggested that disease developed because of the presence of viral resistance and, possibly, low tissue penetration of antiviral agents.
Medical subject headings
- Antiviral Agents
- Bone Marrow Transplantation
- Cytomegalovirus Retinitis
- Cytosine
- Drug Resistance, Viral
- Encephalitis, Viral
- Foscarnet
- Ganciclovir
- Immunocompromised Host
- Organophosphonates
- Organophosphorus Compounds